Company Registration No. 04150179 (England and Wales)
Bioedit Limited
Unaudited financial statements
for the year ended 31 March 2026
Pages for filing with the registrar
Bioedit Limited
Contents
Page
Statement of financial position
1
Notes to the financial statements
2 - 6
Bioedit Limited
Statement of financial position
As at 31 March 2026
1
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
31,562
Current assets
Debtors
5
1,995
56,036
Cash at bank and in hand
5,401
223,275
7,396
279,311
Creditors: amounts falling due within one year
6
(5,956)
(29,478)
Net current assets
1,440
249,833
Net assets
1,440
281,395
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
440
280,395
Total equity
1,440
281,395
The director of the company has elected not to include a copy of the income statement within the financial statements.true
For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 16 September 2026 and are signed on its behalf by:
Patrick Hughes
Director
Company Registration No. 04150179
Bioedit Limited
Notes to the financial statements
For the year ended 31 March 2026
2
1
Accounting policies
Company information
Bioedit Limited is a private company limited by shares incorporated in England and Wales. The registered office is Flat 19, 30 Ludgate Hill, Manchester, England, M4 4TF.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. However, as explained in Note 1.2, the directors have ceased trading. Consequently the financial statements have been prepared on a basis other than that of a going concern. The principal accounting policies adopted are set out below.
1.2
Going concern
During the year, the company ceased trading and the directors have confirmed that there is no intention to recommence operations. As a result, the directors do not consider it appropriate to prepare the financial statements on a going concern basis.true
Accordingly, the financial statements have been prepared on a basis other than going concern. Under this basis, assets have been stated at their estimated realisable amounts and liabilities have been recognised at their expected settlement amounts.
No adjustments have been made to reflect any changes that may arise from the orderly realisation of assets and settlement of liabilities other than those reflected in the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
12.5% reducing balance
Website and computers
4 years straight line
Website costs
5 years straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Bioedit Limited
Notes to the financial statements (continued)
For the year ended 31 March 2026
1
Accounting policies (continued)
3
1.5
Cash at bank and in hand
Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Bioedit Limited
Notes to the financial statements (continued)
For the year ended 31 March 2026
1
Accounting policies (continued)
4
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.10
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.11
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
No significant judgements or estimates have been made during the year.
Bioedit Limited
Notes to the financial statements (continued)
For the year ended 31 March 2026
5
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2026
2025
Number
Number
Total
2
4
The company ceased operating a payroll on 31 October 2025, and had no employees from that point to the year end.
4
Tangible fixed assets
Fixtures and fittings
Website and computers
Total
£
£
£
Cost
At 1 April 2025
5,147
86,090
91,237
Disposals
(5,147)
(86,090)
(91,237)
At 31 March 2026
Depreciation and impairment
At 1 April 2025
4,398
55,277
59,675
Eliminated in respect of disposals
(4,398)
(55,277)
(59,675)
At 31 March 2026
Carrying amount
At 31 March 2026
At 31 March 2025
749
30,813
31,562
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
27,996
Other debtors
1,995
6,035
1,995
34,031
Deferred tax asset
22,005
1,995
56,036
Bioedit Limited
Notes to the financial statements (continued)
For the year ended 31 March 2026
6
6
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
17,633
Taxation and social security
3,680
Other creditors
5,956
8,165
5,956
29,478
7
Directors' transactions
At the year end the company owed £1,413 (2024: £1,449) to a director. This amount is interest free, repayable on demand and included within other creditors.